10.1038/s41391-021-00485-3 - Reducing the number of systematic bio...

This document has been corrected

Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning

10.1038/s41391-021-00485-3

Published Online: 2022-01-14

Journal: Prostate Cancer and Prostatic Diseases•Publisher: Springer Science and Business Media LLC

Authors: Alvin Y. M. Lee•Christopher W. S. Cheng•Han Jie Lee•Henry S. S. Ho•John S. P. Yuen•Kae Jack Tay•Kenneth Chen•Nye Thane Ngo•Stephanie Fook-Chong•Vipatsorn Shutchaidat•Yan Mee Law•Yu Guang Tan

This document has been corrected

Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning

10.1038/s41391-021-00485-3

Published Online: 2022-01-14

Journal: Prostate Cancer and Prostatic Diseases

NOW

2022-02-28•Correction

Correction: Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning

10.1038/s41391-022-00513-w

* information provided by CrossRef

2022-02-28•Correction

10.1038/s41391-022-00513-w

* information provided by CrossRef

2022-01-14•Published

2022-02-28•Correction

Correction: Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning

10.1038/s41391-022-00513-w

* information provided by CrossRef

This document has been corrected

Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning

10.1038/s41391-021-00485-3

Published Online: 2022-01-14

Journal: Prostate Cancer and Prostatic Diseases•Publisher: Springer Science and Business Media LLC